# ShangPharma Innovation

ShangPharma Innovation is a Venture Capital based in South San Francisco, United States.

## Overview

- **Organization type:** Venture Capital
- **Headquarters:** South San Francisco, United States
- **Region:** North America
- **Address:** South San Francisco, CA, United States
- **Founded:** 2016
- **Assets under management:** Undisclosed
- **Website:** spiivc.com
- **LinkedIn:** https://www.linkedin.com/company/shangpharma-innovation

## Regulatory record

- **Reports private funds:** No

## About

ShangPharma Innovation is an incubator and investment organization focused on biomedical R&D technologies and therapeutics. It has made 11 investments, including an unattributed venture capital investment in Azkarra Therapeutics on August 12, 2022.

## Sectors

- Digital Health
- Healthcare Services
- AI/ML

## Questions

### What investment stages and check sizes does ShangPharma Innovation target?

The firm concentrates on seed and Series A opportunities, writing checks into preclinical and early clinical-stage companies. Sectors include small-molecule therapeutics, biologics, diagnostics, and AI-driven drug discovery platforms. While specific check-size ranges are not publicly disclosed, the venture is structured to support capital-efficient biotech startups that can progress through preclinical proof-of-concept without immediately requiring large syndicates, in part because ShangPharma's infrastructure absorbs certain operational costs.

### How is ShangPharma Innovation related to the parent company's CRO business?

ShangPharma Innovation is the venture investing division of ShangPharma, the contract research organization founded in 2002 and headquartered in Shanghai. The parent company provides discovery chemistry, preclinical testing, formulation development, and clinical trial management to pharmaceutical clients globally. The venture arm invests independently but preferentially accesses the parent's service infrastructure for portfolio companies, creating a vertically integrated platform that spans early-stage venture capital through commercial drug development services.

## Related profiles

- [Shanghai Zhonghao Asset Management](https://altss.com/profile/shanghai-zhonghao-asset-management)
- [Shangqi Capital](https://altss.com/profile/shangqi-capital)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/shangpharma-innovation

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology